Learn more about our research and development, engage with captivating topics on sustainability and growth, and gain a fresh perspective on how Camelina can help change the world.
Yield10’s Commercial Sales Manager, Davis McCarthy, PAg, answers grower questions about planting, growing, and harvesting Camelina, a new oilseed crop.
We are thrilled to announce the publication of a paper on our advanced technology enabling the successful coproduction of polyhydroxyalkanoate (“PHA”) biopolymer and oil in the seed of Camelina in the latest issue of Plant Biotechnology Journal.
Yield10’s successful trials of herbicide-tolerant spring Camelina mark a significant moment in the history of North American agriculture. With the company’s plans for seed scale-up of spring HT Camelina and field testing winter HT Camelina this year, the future looks bright.
It has been a busy start to 2023 for Yield10 as we conduct our winter field tests, scale-up Camelina seed for use in 2023, engage with participants in the supply chain for biofuels and recruit farmers to grow Camelina under contract.
Kristi Snell, Ph.D., Yield10 Bioscience’s Chief Science Officer, presented on advancements in producing PHA bioplastic in Camelina at the recent ISBP2022 conference in Sion, Switzerland. The Yield10 R&D team is working to improve prototype Camelina PHB producing lines.
Olly Peoples, Ph.D. has been selected as “AgTech CEO of the Year” in the 2022 AgTech Breakthrough Awards conducted by AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies, and products in the global agricultural and food technology markets.
Yield10 recently confirmed that it has observed herbicide tolerance in field trials of its proprietary Camelina lines.
In June Yield10 Bioscience announced an open enrollment program for growers for contract production of winter Camelina. Farms located in Montana and Idaho, as well as southern Alberta (Canada) and Saskatchewan (Canada), are eligible to participate in the program.
Yield10’s CEO Dr. Olly Peoples discusses with Dr. Kevin Folta host of the Talking Biotech podcast about the development of Camelina as a new commercial crop in North America.
Dr. Oliver Peoples, the CEO of Yield10 Bioscience explains the use of Camelina seed oil as a potential source of biofuel and discusses its implications in the transportation industry in a podcast for Energi Media, hosted by Markham Hislop.
